Guang Hu

Dr. Hu joined IASO Biotherapeutics in January 2018, and is currently the company’s Vice President for Research & Development.

Dr. Hu has a Ph.D. in Molecular Biology from the Institute of Biophysics, Chinese Academy of Sciences. He underwent postdoctoral training in clinical oncology research at the Harvard Medical School and was a Visiting Scholar at Stanford University School of Medicine. Before joining IASO Biotherapeutics, Dr. Hu served as General Manager of Beijing Sirnoa Biotechnology Co., Ltd., and Director of Shaoxing Research Institute of College of Engineering, Peking University. Since returning to China in 2015 Dr. Hu has been involved in research and development of CAR-T cell therapies.